Leading the Way in Life Science Technologies

GEN Exclusives

More »

Jan. 15, Vol. 26, No. 2

    • Columns

      • Corporate Partnering Status Report
      • Corporate Partnering is the creation of a contractual (almost joint venture) relationship between an innovator company, with respect to its compound, drug, or technology, and another company with cash or operational resources that can be deployed to ... more »
      • Steps for Preventing the Misuse of Biological Research
      • The misuse of biological research is increasingly becoming a prominent policy concern. In addition to the biosafety and biosecurity regulations currently in place to oversee biological research, it is now argued that measures are also needed to prev ... more »
    • Feature Articles

      • DeveloGen Tackles Metabolic Disorders
      • Sophia Fox
      • German biopharmaceutical company DeveloGen (www. develogen.com) initiated European Phase III trials with its lead diabetes immunotherapy product, DiaPep277.The company also recently presented positive results from two Phase II trials of DiaPep277 in ... more »
      • Development of Stem Cell Technologies
      • Despite rapid advances in life science research, the bioindustry has been plagued by a slowdown in new drug, biologic, and medical device applications. Indeed, the FDA addressed this issue two years ago with the release of a white paper entitled Cha ... more »
      • French Biotech on the Upturn
      • There was a new mood of optimism about French biotech at the recent 9th European Biotech Crossroads meeting in Lille. The reason was that France recently had its first biotech IPOs since 1999 with the float on Euronext of ExonHit Therapeutic (www.ex ... more »
      • New Biomolecules for Cancer Treatment
      • At the recent 9th European Biotech Crossroads meeting in Lille, France, Nigel Courtenay-Luck, Ph.D., CSO of Antisoma (www.anti soma.com), presented encouraging safety data from a Phase I study of a new type of biomolecule known as an aptamer. Accor ... more »
      • New York City Pursues Biotechnology Dream
      • New York City has plans to develop the metropolitan areas largest commercial bioscience park, to be built in two stages on 4.25 acres for $700 million. The East River Science Park will be constructed on the Bellevue Hospital campus. Mayor Michael Bl ... more »
    • Tutorials

      • Assay: Protein Microarrays on Nitrocellulose Slides
      • Protein microarrays offer the ability to measure protein expression and antibody binding in a high-throughput and miniaturized manner. DNA microarrays (cDNA or oligos) have become commonplace and instrumentation is available to automate the workflow ... more »
      • Embryonic Stem Cell Research Operations
      • The beginning of embryonic stem cell (ESC) research can be pegged to 1981 when the first reports of the derivation of mouse embryonic stem cells (mESC) were made.1,2 Scientists subsequently showed that mESC could be genetically manipulated in vitro. ... more »
      • Proteomics-Based Biomarker & Drug Discovery
      • The discovery of novel protein biomarkers will revolutionize the diagnosis, treatment, and prevention of disease, but, in addition, upstream of the clinical arena, protein biomarkers have the potential to accelerate and refine the drug discovery pro ... more »

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »